Meridian Bioscience, Inc. (NASDAQ:VIVO)

CAPS Rating: 5 out of 5

A fully-integrated life science company whose principal businesses are development, manufacture, sale and distribution of diagnostic test kits; manufacture and distribution of bulk antigens and reagents; and manufacture of proteins and other biologicals.

Recs

0
Player Avatar GMoneyCaps (70.19) Submitted: 12/13/2011 7:42:23 PM : Outperform Start Price: $18.16 VIVO Score: -2.16

12/13

Featured Broker Partners


Advertisement